Mayer Brown advises Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, on the financing of the acquisition of Dutscher Group, the European leader in consumables and equipment distribution for R&D laboratories. The transaction, which is expected to close during the first half of 2026, subject to regulatory approvals.
The deal will mark Vivo Capital’s first buyout investment in Europe and underscores the firm’s continued expansion as a global healthcare investor, building on its long-standing leadership across North America and Asia
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
